DG
14
-3
FLR
46
-2
AVB
57
-2
UA
38
-9
INTU
59
-3
AMG
54
-4
VZ
39
2
MU
42
7
SRE
47
2
KEY
31
2
BIIB
38
-2
PGR
59
5
GOOGL
67
-2
STZ
54
2
ORCL
52
-7
GT
56
-2
TDC
81
5
GIS
49
12
UNP
43
3
IPG
49
2
DG
14
-3
FLR
46
-2
AVB
57
-2
UA
38
-9
INTU
59
-3
AMG
54
-4
VZ
39
2
MU
42
7
SRE
47
2
KEY
31
2
BIIB
38
-2
PGR
59
5
GOOGL
67
-2
STZ
54
2
ORCL
52
-7
GT
56
-2
TDC
81
5
GIS
49
12
UNP
43
3
IPG
49
2
Financhill
Back

NORMA Group SE 10K Form

Sell
44

NOEJF
NORMA Group SE

Last Price:
20.15
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NOEJF News And Ratings

See the #1 stock for the next 7 days that we like better than NOEJF

NOEJF Financial Statistics

Sales & Book Value

Annual Sales: $1.32B
Cash Flow: $36.83M
Price / Cash Flow: 5.02
Annual Sales: $24.29
Price / Book: 0.83

Profitability

EPS (TTM): 0.78590
Net Income (TTM): $25.5M
Gross Margin: $723.16M
Return on Equity: 3.34%
Return on Assets: 1.57%

NORMA Group SE Earnings Forecast

Key NORMA Group SE Financial Ratios

  • The Gross Profit Margin over the past 15 years for NOEJF is 54.63%.
  • The Selling, General & Administrative Expenses for NOEJF have been equal to 8.30% of Gross Profit Margin.
  • The Research & Development expenses have been 0.15% of Revenue.
  • The Interest Expense is 86.52% of Operating Income.
  • The Net Earning history of NOEJF is 2.28% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 8 years.

NORMA Group SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Machinery
Sector: Industrials
Current Symbol: NOEJF
Website: normagroup.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 2.35
Quick Ratio: 1.36

Price-to-Earnings

Trailing P/E Ratio: 21.39
Forward P/E Ratio: 0

NOEJF Technical Analysis vs Fundamental Analysis

Sell
44
NORMA Group SE (NOEJF) is a Sell

Is NORMA Group SE a Buy or a Sell?

  • NORMA Group SE stock is rated a Sell
    The current NORMA Group SE [NOEJF] share price is $20.15. The Score for NOEJF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.